* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Primary human immunodeficiency virus type 1 infection: clinical
Survey
Document related concepts
Traveler's diarrhea wikipedia , lookup
Urinary tract infection wikipedia , lookup
Gastroenteritis wikipedia , lookup
Hepatitis C wikipedia , lookup
Schistosomiasis wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Marburg virus disease wikipedia , lookup
Common cold wikipedia , lookup
Neonatal infection wikipedia , lookup
West Nile fever wikipedia , lookup
Sarcocystis wikipedia , lookup
Henipavirus wikipedia , lookup
Transcript
Clin Infect Dis. 2000 Mar;30(3):486-90. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Lavreys L1, Thompson ML, Martin HL Jr, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss J. Author information Departments of Epidemiology, Medicine, and Biostatistics, University of Washington, Seattle, WA 98104-2499, USA. Abstract The occurrence of clinical manifestations associated with primary human immunodeficiency virus type 1 (HIV-1) infection was evaluated in a prospective cohort study of female sex workers in Mombasa, Kenya. Among 103 women who seroconverted to HIV-1, fever, vomiting, diarrhea, headache, arthralgia, myalgia, skin rash, swollen lymph nodes, extrainguinal lymphadenopathy, inguinal lymphadenopathy, and vaginal candidiasis were noted significantly more frequently at visits in which seroconversion first became evident. Eighty-one percent of seroconverting women had >/=1 of these 11 symptoms or signs. Among 44% of the women, the acute illness was severe enough to prevent them from working. Having >/=2 of 6 selected symptoms and signs yielded a sensitivity of 51%, specificity of 83%, positive likelihood ratio of 3.2, and negative likelihood ratio of 0.5 for acute HIV-1 infection. The recognition of primary HIV-1-infection illness in high-risk populations and subsequent risk-reduction counseling could potentially reduce secondary HIV-1 transmission during this highly infectious period. PMID: 10722432 [PubMed - indexed for MEDLINE]